Ichiro Hisatome
Overview
Explore the profile of Ichiro Hisatome including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
247
Citations
3453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuwabara M, Hisatome I, Ae R, Kosami K, Aoki Y, Andres-Hernando A, et al.
Nutr Metab Cardiovasc Dis
. 2025 Feb;
35(3):103796.
PMID: 39939254
Background And Aims: Hyperuricemia is strongly linked to increased cardiovascular risk, including hypertension, coronary artery disease, arrythmia, and heart failure. Uric acid, as the end-product of purine metabolism, plays a...
2.
Kuwabara M, Ohtani N, Hisatome I
Lancet Rheumatol
. 2025 Feb;
7(3):e160-e161.
PMID: 39929224
No abstract available.
3.
Kuwabara M, Ae R, Kosami K, Kanbay M, Andres-Hernando A, Hisatome I, et al.
Hypertens Res
. 2024 Dec;
48(2):867-873.
PMID: 39627392
Uric acid, the final product of purine metabolism, plays a significant role in hypertension Research on uric acid has advanced significantly, particularly regarding its links to hypertension and cardiovascular disease...
4.
Hisatome I
No Shinkei Geka
. 2024 Dec;
52(6):1167-1178.
PMID: 39622322
Hyperuricemia causes not only gout but also organ damage, such as through cerebrovascular, cardiovascular, and lifestyle-related diseases. The relationship between the serum urate(SUA)level and organ damage has recently been redefined...
5.
Sugihara S, Yamamoto Y, Teramoto K, Hamada T, Miyazaki S, Ogino K, et al.
Clin Exp Nephrol
. 2024 Oct;
29(2):173-181.
PMID: 39361182
Background: Extremely low uric acid (UA) levels or increased urinary UA (Uua) excretion might be risk factors for kidney disease in renal hypouricemia (RHU) patients, but their relationship with kidney...
6.
Hisatome I, Tomita K, Kato R, Ikeuchi T, Touge H, Hamada T, et al.
Intern Med
. 2024 Sep;
PMID: 39261072
Background Hypouricemia, defined as a serum uric acid (SUA) level ≤2 mg/dL, could be a risk factor for death in hospitalized patients. However, how explanatory variables can explain hypouricemia as...
7.
Oshima Y, Tanaka A, Fukuki M, Otsuki A, Hisatome I
Yonago Acta Med
. 2024 Aug;
67(3):270-279.
PMID: 39176192
Aconite contains four highly toxic diester-diterpene alkaloids, including aconitine, mesaconitine, hypaconitine, and jesaconitine, in all plant parts. Aconite has been used as for suicide, murder, and as an arrow poison...
8.
Minato H, Endo R, Kurata Y, Notsu T, Kinugasa Y, Wakimizu T, et al.
Heart Vessels
. 2024 May;
39(10):899-908.
PMID: 38797744
It remains to be elucidated whether Ca antagonists induce pharmacological preconditioning to protect the heart against ischemia/reperfusion injury. The aim of this study was to determine whether and how pretreatment...
9.
Sugawara M, Kojima S, Hisatome I, Matsui K, Uchiyama K, Yokota N, et al.
Clin Pharmacol Ther
. 2024 Feb;
115(6):1358-1364.
PMID: 38389505
A recent meta-analysis found no benefit of uric acid-lowering therapy including febuxostat on death, cardiovascular events, or renal impairment. However, there may be populations that benefit from febuxostat in reducing...
10.
Kuwabara M, Nakai M, Sumita Y, Iwanaga Y, Ae R, Kodama T, et al.
Front Pharmacol
. 2024 Jan;
14:1289386.
PMID: 38259292
This study investigates the impact of xanthine oxidase inhibitors (XOI) on mortality in patients with cardiovascular diseases. XOI withdrawal has been reported to increased mortality risk due to rapid adenosine...